Integrated Disease Management for Chronic Obstructive Pulmonary Disease in Primary Care, from the Controlled Trial to Clinical Program: A Cohort Study

References

• Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease. Report; 2022. Available from: https://goldcopd.org/wp-content/uploads/2021/11/GOLD-REPORT-2022-v1.0-12Nov2021_WMV.pdf. Accessed November, 2021.
   Google Scholar
• Bourbeau J, Bhutani M, Hernandez P, et al. Canadian Thoracic Society Clinical Practice Guideline on pharmacotherapy in patients with COPD – 2019 update of evidence. Can J Respir Crit Care Sleep Med. 2019;3(4):210–232. doi:10.1080/24745332.2019.1668652
   Web of Science ®Google Scholar
• Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. The Lancet. 2019;379(9823):1341–1351. doi:10.1016/S0140-6736(11)60968-9
   Web of Science ®Google Scholar
• Yawn BP, Kim V. Treatment options for stable chronic obstructive pulmonary disease: current recommendations and unmet needs. Cleve Clin J Med. 2018;85(2 Suppl 1):S28–S37. doi:10.3949/ccjm.85.s1.05
   PubMedGoogle Scholar
• Cho EE, Mecredy GC, Wong HH, Stanbrook MB, Gershon AS. Which physicians are taking care of people with COPD? Chest. 2019;155(4):771–777. doi:10.1016/j.chest.2018.12.018
   PubMed Web of Science ®Google Scholar
• Bellamy D, Bouchard J, Henrichsen S, et al. International Primary Care Respiratory Group (IPCRG) Guidelines: management of chronic obstructive pulmonary disease (COPD). Prim Care Respir J. 2006;15(1):48–57. doi:10.1016/j.pcrj.2005.11.003
   PubMedGoogle Scholar
• Adeloye D, Chua S, Lee C, Basquill C, Papana A, Theodoratou E, et al. Global and regional estimates of COPD prevalence: Systematic review and meta-analysis. J Glob Health.. 2015;5(2)
   Google Scholar
• Public Health Infobase: Canadian Chronic Disease Surveillance System (CCDSS). PHAC; 2017. Available from: https://health-infobase.canada.ca/ccdss/data-tool/. AccessedAugust 21, 2020.
   Google Scholar
• Hernandez P, Balter MS, Bourbeau J, Chan CK, Marciniuk DD, Walker SL. Canadian practice assessment in chronic obstructive pulmonary disease: respiratory specialist physician perception versus patient reality. Can Respir J. 2013;20(2):97–105. doi:10.1155/2013/369019
   PubMed Web of Science ®Google Scholar
• Bourbeau J, Sebaldt RJ, Day A, et al. Practice Patterns in the management of chronic obstructive pulmonary disease in primary practice: the Cage study. Can Respir J. 2008;15(1):13–19. doi:10.1155/2008/173904
   PubMed Web of Science ®Google Scholar
• Agusti A, Calverley PMA, Celli B, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010;11(3). doi:10.1186/1465-9921-11-122.
   PubMed Web of Science ®Google Scholar
• Philip K, Gaduzo S, Rogers J, Laffan M, Hopkinson NS. Patient experience of COPD care: outcomes from the British Lung Foundation Patient Passport. BMJ Open Respir Res. 2019;6(1):1–5.
   Web of Science ®Google Scholar
• Gregoriano C, Dieterle T, Breitenstein AL, et al. Use and inhalation technique of inhaled medication in patients with asthma and COPD: data from a randomized controlled trial. Respir Res. 2018;19(1):1–15. doi:10.1186/s12931-018-0936-3
   PubMedGoogle Scholar
• Wagner EH. The role of patient care teams in chronic disease management. Br Med J. 2000;320(7234):569–572. doi:10.1136/bmj.320.7234.569
   PubMedGoogle Scholar
• Kruis AL, Smidt N, Assendelft WJ, et al. Integrated disease management interventions for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2013;10:CD009437. doi:10.1002/14651858.CD009437.pub2
   PubMed Web of Science ®Google Scholar
• Zwerink M, Brusse‐Keizer M, van der Valk P, et al. Self management for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2014;3. doi:10.1002/14651858.CD002990.pub3
   PubMed Web of Science ®Google Scholar
• Lenferink A, Brusse-Keizer M, van der Valk PD, et al. Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2017;8(8):CD011682. doi:10.1002/14651858.CD011682.pub2
   PubMed Web of Science ®Google Scholar
• Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA. 2002;288(14):1775–1779. doi:10.1001/jama.288.14.1775
   PubMed Web of Science ®Google Scholar
• Norris SL, Glasgow RE, Engelgau MM, et al. Chronic disease management. Dis Manage Health Outcomes. 2003;11:477–488. doi:10.2165/00115677-200311080-0000118
   Google Scholar
• Schrijvers G. Disease management: a proposal for a new definition. Int J Integr Care. 2009;9(March):2008–2010. doi:10.5334/ijic.301
   Google Scholar
• Poot CC, Meijer E, Kruis AL, Smidt N, Chavannes NHHP, Honkoop PJ. Integrated disease management interventions for patients with chronic obstructive pulmonary disease (Review). Cochrane Database Syst Rev. 2021;9(9). doi:10.1002/14651858.CD009437.pub3
   PubMed Web of Science ®Google Scholar
• Kruis AL, Boland MRS, Assendelft WJJ, et al. Effectiveness of integrated disease management for primary care chronic obstructive pulmonary disease patients: results of cluster randomised trial. BMJ. 2014;349:g5392. doi:10.1136/bmj.g5392
   PubMed Web of Science ®Google Scholar
• Bischoff EWMA, Akkermans R, Bourbeau J. Comprehensive self management and routine monitoring in chronic obstructive pulmonary disease patients in general practice: randomised controlled trial. BMJ. 2012;7642(November):1–12. doi:10.1136/bmj.e7642
   Web of Science ®Google Scholar
• Ferrone M, Masciantonio MG, Malus N, et al. The impact of integrated disease management in high-risk COPD patients in primary care. Npj Prim Care Respir Med. 2019;29(1):8. doi:10.1038/s41533-019-0119-9
   PubMed Web of Science ®Google Scholar
• Freund T, Peters-Klimm F, Boyd C, et al. Medical assistant-based care management for high-risk patients in small primary care practices: a cluster randomized clinical trial. Ann Intern Med. 2016;164(5):323–330. doi:10.7326/M14-2403
   PubMed Web of Science ®Google Scholar
• Lou P, Chen P, Mph PZ, Yu J, Wang Y. A COPD health management program in a community-based primary care setting: a randomized controlled trial. Respir Care. 2015;60(1):102–112. doi:10.4187/respcare.03420
   PubMed Web of Science ®Google Scholar
• Chavannes NH, Grijsen M, Van Den AM, et al. Integrated disease management improves one-year quality of life in primary care COPD patients: a controlled clinical trial. Primary Care Respiratory Journal: Journal of the General Practice Airways Group. 2009;18:171–176. doi:10.3132/pcrj.2009.00003
   PubMedGoogle Scholar
• Lisspers K, Johansson G, Jansson C, et al. Improvement in COPD management by access to asthma/COPD clinics in primary care: data from the observational PATHOS study. Respir Med. 2014;108(9):1345–1354. doi:10.1016/j.rmed.2014.06.002
   PubMed Web of Science ®Google Scholar
• Monteagudo M, Rodríguez-Blanco T, Llagostera M, et al. Factors associated with changes in quality of life of COPD patients: a prospective study in primary care. Respir Med. 2013;107(10):1589–1597. doi:10.1016/j.rmed.2013.05.009
   PubMed Web of Science ®Google Scholar
• Smid DE, Franssen FME, Houben-Wilke S, et al. Responsiveness and MCID estimates for CAT, CCQ, and HADS in patients with COPD undergoing pulmonary rehabilitation: a prospective analysis. J Am Med Dir Assoc. 2017;18(1):53–58. doi:10.1016/j.jamda.2016.08.002
   PubMed Web of Science ®Google Scholar
• Kon SSC, Canavan JL, Jones SE, et al. Minimum clinically important difference for the COPD Assessment Test: a prospective analysis. Lancet Respir Med. 2014;2(3):195–203. doi:10.1016/S2213-2600(14)70001-3
   PubMed Web of Science ®Google Scholar
• Alma H, De Jong C, Jelusic D, et al. Health status instruments for patients with COPD in pulmonary rehabilitation: defining a minimal clinically important difference. Prim Care Respir J. 2016;26(1). doi:10.1038/npjpcrm.2016.41
   Google Scholar
• Sedgwick P, Greenwood N. Understanding the Hawthorne effect. BMJ. 2015;351:1–2.
   Google Scholar
• Rothwell PM. Factors that can affect the external validity of randomised controlled trials. PLoS Clin Trials. 2006;1(1):e9. doi:10.1371/journal.pctr.0010009
   PubMedGoogle Scholar
• Bertens LCM, Reitsma JB, Moons KGM, et al. Development and validation of a model to predict the risk of exacerbations in chronic obstructive pulmonary disease. Int J COPD. 2013;8:493–499. doi:10.2147/COPD.S49609
   Google Scholar
• Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138. doi:10.1056/NEJMoa0909883
   PubMed Web of Science ®Google Scholar
• Adibi A, Sin DD, Safari A, et al. The Acute COPD Exacerbation Prediction Tool (ACCEPT): a modelling study. Lancet Respir Med. 2020;8(10):1013–1021. doi:10.1016/S2213-2600(19)30397-2
   PubMed Web of Science ®Google Scholar
• Meijer E, Van Eeden AE, Kruis AL, et al. Exploring characteristics of COPD patients with clinical improvement after integrated disease management or usual care: post-hoc analysis of the RECODE study. BMC Pulm Med. 2020;20(1):1–10. doi:10.1186/s12890-020-01213-838
   PubMed Web of Science ®Google Scholar
• Jones PW, Anderson JA, Calverley PMA, et al. Health status in the TORCH study of COPD: treatment efficacy and other determinants of change. Respir Res. 2011;12:1–8. doi:10.1186/1465-9921-12-71
   PubMed Web of Science ®Google Scholar
• Eisner MD, Blanc PD, Omachi TA, et al. Socioeconomic status, race, and COPD health outcomes. J Epidemiol Community Heal. 2011;65(1):26–34. doi:10.1136/jech.2009.089722
   PubMed Web of Science ®Google Scholar
• Matheson FI, van Ingen T. Ontario Marginalization Index: User Guide. Toronto, ON: St. Michael’s Hospital; 2018. Joint publication with Public Health Ontario; 2016.
   Google Scholar
• Wolff RF, Moons KGM, Riley RD, et al. PROBAST: a tool to assess the risk of bias and applicability of prediction model studies. Ann Intern Med. 2019;170(1):51–58. doi:10.7326/M18-1376
   PubMed Web of Science ®Google Scholar
• Spertus JA, Jones PG, Sandhu AT, Arnold SV. Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical Care: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020;76(20):2379–2390. doi:10.1016/j.jacc.2020.09.542
   PubMed Web of Science ®Google Scholar
• Sterne JAC, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;339(7713):157–160.
   Google Scholar
• Bhaskaran K, Smeeth L. What is the difference between missing completely at random and missing at random? Int J Epidemiol. 2014;43(4):1336–1339. doi:10.1093/ije/dyu080
   PubMed Web of Science ®Google Scholar
• Habraken JM, Van Der Wal G, Riet T, Weersink EJM, Tobene F, Bindels PJE. Health-related quality of life and functional status in end-stage COPD: a longitudinal study. Eur Respir J. 2011;37(2):280–288. doi:10.1183/09031936.00149309
   PubMed Web of Science ®Google Scholar
• Nagai K, Makita H, Suzuki M, et al. Differential changes in quality of life components over 5 years in chronic obstructive pulmonary disease patients. Int J COPD. 2015;10:745–757. doi:10.2147/COPD.S77586
   Google Scholar
• Peters M, Crocker H, Dummett S, et al. Change in health status in long-term conditions over a one year period: a cohort survey using patient-reported outcome measures. Health Qual Life Outcomes. 2014;12(1):1–10. doi:10.1186/s12955-014-0123-2
   Google Scholar
• Wilke S, Jones PW, Müllerova H, et al. One-year change in health status and subsequent outcomes in COPD. Thorax. 2015;70(5):420–425. doi:10.1136/thoraxjnl-2014-205697
   PubMed Web of Science ®Google Scholar
• Jones PW, Adamek L, Nadeau G, Banik N. Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification. Eur Respir J. 2013;42(3):647–654. doi:10.1183/09031936.00125612
   PubMed Web of Science ®Google Scholar
• Jakeways N, McKeever T, Lewis SA, Weiss ST, Britton J. Relationship between FEV1 reduction and respiratory symptoms in the general population. Eur Respir J. 2003;21(4):658–663. doi:10.1183/09031936.03.00069603
   PubMed Web of Science ®Google Scholar
• Waschki B, Kirsten AM, Holz O, et al. Disease progression and changes in physical activity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;192(3):295–306. doi:10.1164/rccm.201501-0081OC
   PubMed Web of Science ®Google Scholar
• Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M. Longitudinal deteriorations in patient reported outcomes in patients with COPD. Respir Med. 2007;101(1):146–153. doi:10.1016/j.rmed.2006.04.001
   PubMed Web of Science ®Google Scholar